期刊文献+

CVB3腺病毒载体疫苗Ad/MDC—VP1与DNA疫苗联合应用的免疫效果 被引量:6

The immunological effect of Ad/MDC-VP1 combined with DNA vaccine against Coxsackievirus infection
原文传递
导出
摘要 目的构建重组腺病毒Ad/MDC—VP1,观察Ad/MDC-VPl与DNA疫苗联合应用的免疫效果。方法构建、包装重组腺病毒Ad/MDC—VP1并检测目的蛋白的表达。BALB/c小鼠随机分为Ad/MDC—VPl、pcDNA3/MDC—VP1、pcDNA3/MDC-VP1+Ad/MDC—VP1和PBS4组,肌肉注射免疫小鼠。用ELISA法和微量中和试验法分别检测血清柯萨奇病毒B3(CVB3)VP1 IgG和中和抗体滴度;CCK-8法检测淋巴细胞增殖活性和特异性CTL杀伤活性;用致死量CVB3攻击小鼠后,检测血中病毒滴度并观察小鼠的存活率。结果成功构建并包装了重组腺病毒Ad/MDC-VPI,检测到目的蛋白的表达。pcDNA3/MDC.VP1+Ad/MDC—VP1组血清CVB3VP1IgG滴度、淋巴细胞增殖指数、CTL杀伤酒生和对小鼠的保护率明显高于其他各组(P〈0.05),血清病毒滴度低于其他各组(P〈0.05)。结论Ad/MDC—VP1与DNA疫苗联合应用能显著提高小鼠细胞和体液免疫应答。 Objective To construct recombinant adenovirus Ad/MDC-VP1 and investigate its immuno-boosting effect of the mice primed with the experimental DNA vaccine against Coxsackievirus infection. Methods The recombinant adenovirus Ad/MDC-VP1 was constructed and packaged. The Western blot analysis was used to verify the target protein. BALB/c mice were divided into four groups: Ad/MDC-VP1 group, pcDNA3/MDC-VP1 group, pcDNA3/MDC-VP1 prime-Ad/MDC-VP1 boost group and PBS group. The mice in each group were immunized intramuscularly. The titers of serum IgG and neutralizing antibody were tested by ELISA and trace neutralization assay, respectively. The lymphocytes proliferation activity and specific CTL cytotoxic activity were tested by CCK-8 assay. The mice in each group were challenged with lethal dose of Coxsackievirus, and the assay of the serum virus titers and the observation of protection efficacy against Coxsackievirus infection were carried out. Results The recombinant adenovirus Ad/MDC-VP1 was successfully constructed and the target protein was expressed. It was observed that the titers of CVB3 VP1 specific antibody, lymphocyte stimulation index, CTL cytotoxicity activities and protection rate of the pcDNA3/MDC-VPl prime-Ad/MDC-VP1 boost group were much higher than those of the rest groups(P 〈 0.05), and the titer of serum virus was Lower after CVB3 challenged ( P 〈 0.05 ). Cottclusion Both the cellular and humoral immune responses in mice could been significantly enhanced by the pcDNA3/MDC-VP1 prime-Ad/MDC-VP1 boost strategy.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2009年第6期533-537,共5页 Chinese Journal of Microbiology and Immunology
基金 河北省科技支撑计划(072761896) 河北省医学科学研究重点课题(08258)
关键词 柯萨奇病毒B3 腺病毒载体疫苗 DNA疫苗 Prime—boost免疫策略 Coxsackievirus B3 Adenovirus vector vaccine DNA vaccine Prime-boost immunization strategy
  • 相关文献

参考文献8

  • 1Henke A,Wagner E,Whitton JL,et al.Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization.Virol,1998,72(10):8327-8331.
  • 2韩小艳,赵娜,高志云,揣侠,羡鲜,蓝佳明,张永红,王永祥.接头长度对MDC与CVB3VP1融合基因疫苗免疫效果的影响[J].中华微生物学和免疫学杂志,2007,27(12):1145-1149. 被引量:9
  • 3J萨母布鲁克,DW拉塞尔,黄培堂,译.分子克隆实验指南:3版.北京:科学出版社,1998:26-96.
  • 4He TC,Zhou S,da Costa LT,et al.A simplified system for generating recombinant adenoviruses.Proc Natl Aced Sci USA,1998,95 (5):2509-2514.
  • 5Sullivan NJ,Sanches A,Rollin PE,et al.Development of a preventive vaccine for Ebola virus infection in primates.Nature,2000,408(6812):605-609.
  • 6方艳辉,金玉怀,王永祥,于丹军,金士香,谢立新.人IL-2信号肽基因增强柯萨奇病毒B3型VP1 DNA疫苗诱导的中和抗体应答[J].中华微生物学和免疫学杂志,2004,24(3):202-205. 被引量:11
  • 7赵娜,韩小艳,王晓凌,李剑,李伟,谢立新,李琳,王永祥.C3d对分泌型柯萨奇病毒B组3型VP1 DNA疫苗的免疫增强作用[J].中华医学杂志,2007,87(36):2561-2563. 被引量:10
  • 8Wang S,Kennedy JS,West K,et al.Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA primeprotein boost HIV-1 vaccine in healthy human volunteers.Vaccine,2008,26(31):3947-3957.

二级参考文献22

共引文献23

同被引文献96

  • 1程驰,章欢,赵先平,高荣.DNA疫苗安全性的策略探究[J].四川动物,2012,31(2):328-331. 被引量:2
  • 2王晓凌,吴淑慧,高志云,王永祥.靶向基因疫苗pcDNA3/MDC-VP1的构建及免疫效果[J].河北大学学报(自然科学版),2006,26(1):16-20. 被引量:3
  • 3李臻,金宁一,金洪涛,沈国顺,付延军,辛苏文,韩贞珍,刘玉生.HIV多表位核酸疫苗构建及其免疫原性[J].中国生物制品学杂志,2007,20(3):178-180. 被引量:3
  • 4付延军,金宁一,金洪涛,李臻,辛苏文,李萍,韩贞珍,李太元.DNA表达载体构建及HIV多表位核酸疫苗的设计与表达[J].中国生物制品学杂志,2007,20(4):237-239. 被引量:2
  • 5Sato Y, Roman M, Tighe H, et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization [J]. Science, 1996, 273 (5273) : 352-354.
  • 6Leitner WW, Ying H, Driver DA, et al. Enhancement of tumorspecific immune response with plasmid DNA replicon vectors [J]. Cancer Res, 2000, 60 (1): 51-55.
  • 7Roy M J, Wu MS, Barr LJ, et al. Induction of antigen-specific CD8+ T cells, T helper ceils, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine [J]. Vaccine, 2000, 19 (7-8): 764-778.
  • 8Drape RJ, Macklin MD, Barr LJ, et al. Epidermal DNA vaccine for influenza is immunogenic in humans [J]. Vaccine, 2006, 24 (21) : 4475-4481.
  • 9Tavel JA, Martin JE, Kelly GG, et al. Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects [J]. J Acquir Immune Defic Syndr, 2007, 44 (5): 601-605.
  • 10Otten G, Schaefer M, Doe B, et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation [J]. Vaccine, 2004, 22 (19): 2489-2493.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部